Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics

Sexually Transmitted Diseases

Volumn 36, Issue 10, 2009, Pages 598-606

  Gaydos, Charlotte ^a   Maldeis, Nancy E ^b   Hardick, Andrew ^a   Hardick, Justin ^a   Quinn, Thomas C ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DNA FINGERPRINTING; FEMALE; GONORRHEA; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MIXED INFECTION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOPLASMA GENITALIUM; MYCOPLASMOSIS; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UNITED STATES; UNIVARIATE ANALYSIS; UTERINE CERVICITIS;

ADULT; CHLAMYDIA TRACHOMATIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; RISK FACTORS; TRICHOMONAS VAGINALIS; UTERINE CERVICITIS;

EID: 70350491297     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181b01948     Document Type: Article

References (46)

1. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among Am youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10.
2. Paavonen J, Critchlow CW, DeRouen T, et al. Etiology of cervical inflammation. Am J Obstet Gynecol 1986; 154:556-564.
3. Brunham RC, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis-the ignored counterpart in women of urethritis in men. N Engl J Med 1984; 311:1-6.
4. Marrazzo JM. Mucopurulent cervicitis: No longer ignored, but still misunderstood. Infect Dis Clin North Am 2005; 19:333-349.
5. Cohen CR, Manhart LE, Bukusi EA, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359:765-766.
6. Holmes K, Stamm WE. Lower genital tract infection syndromes in women. In: Homes KK, Sparling F, Mardh PA, et al., eds. Sexually Transmitted Diseases, 3rd ed. New York, NY: McGraw-Hill, 1999:761-781.
7. Marrazzo JM, Celum CL, Hillis SD, et al. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chla-mydia control strategy. Sex Transm Dis 1997; 24:131-141.
8. Marrazzo JM, Handsfield HH, Whittington WL. Predicting chlamydial and gonococcal cervical infection: Implications for management of cervicitis. Obstet Gynecol 2002; 100:579-584.
9. Cohen CR, Mugo NR, Astete SG, et al. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute sal-pingitis. Sex Transm Infect 2005; 81:463-466.
10. Manhart LE, Critchlow CW, Holmes KK, et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003; 187: 650-657.
11. Schlicht MJ, Lovrich SD, Sartin JS, et al. High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin. J Clin Microbiol 2004; 42:4636-4640.
12. Short VL, Totten PA, Ness RB, et al. Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis 2009; 48:41-47.
13. Hjorth SV, Bjornelius E, Lidbrink P, et al. Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J Clin Microbiol 2006; 44:2078-2083.
14. Gaydos CA, Quinn TC, Willis D, et al. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol 2003; 41:304-309.
15. Chernesky MA, Martin DH, Hook EW, et al. Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs. J Clin Microbiol 2005; 43:127-131.
16. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia tracho-matis and Neisseria gonorrhoeae: Results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005; 32:725-728.
17. Hardick A, Hardick J, Wood BJ, et al. Comparison between the Prototype Gen-Probe TMA Trichomonas vaginalis assay and a Real-time PCR for Trichomonas vaginalis using the Roche Lightcycler Instrument in Female self-administered vaginal swabs and Male urine samples. J Clin Microbiol 2006; 44: 4197-4199.
18. Hardick J, Yang S, Lin S, et al. Use of the Roche LightCycler instrument in a real-time PCR for Trichomonas vaginalis in urine samples from females and males. J Clin Microbiol 2003; 41: 5619-6522
19. Yoshida T, Deguchi T, Ito M, et al. Quantitative detection of Mycoplasma genitalium from first-pass urine of men with ure-thritis and asymptomatic men by real-time PCR. J Clin Microbiol 2002; 40:1451-1455.
20. Jensen JS, Borre MB, Dohn B. Detection of Mycoplasma geni-talium by PCR amplification of the 16S rRNA gene. J Clin Microbiol 2003; 41:261-266.
21. Hardick J, Giles J, Hardick A, et al. Performance of the gen-probe transmission-mediated amplification research assay compared to that of a multitarget real-time PCR for Mycoplasma genitalium detection. J Clin Microbiol 2006; 44:1236-1240.
22. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22.
23. Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK, Sparling FP, Mardh P, et al., eds. Sexually Transmitted Diseases, 3rd ed. New York, NY: McGraw Hill, 1999: 407-422.
24. Quinn TC. Association of sexually transmitted diseases and infection with the human immunodeficiency virus: Biological co-factors and markers of behavioral interventions. Int J STD AIDS 1996; 7(suppl 2):17-24.
25. Lyss SB, Kamb ML, Peterman TA, et al. Chlamydia trachomatis among patients infected with and treated for Neisseria gonor-rhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med 2003; 139:178-185.
26. Wendel KA, Erbelding EJ, Gaydos CA, et al. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal tricho-moniasis. Clin Infect Dis 2002; 35:576-580.
27. Soper D. Trichomoniasis: Under control or undercontrolled? Am J Obstet Gynecol 2004; 190:281-290.
28. Madico G, Quinn TC, Rompalo A, et al. Diagnosis of Trichomo-nas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998; 36:3205-3210.
29. Wendel KA, Erbelding EJ, Gaydos CA, et al. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Infect 2003; 79:151-153.
30. Kaydos SC, Swygard H, Wise SL, et al. Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol 2002; 40:89-95.
31. Uno M, Deguchi T, Komeda H, et al. Mycoplasma genitalium in the cervices of Japanese women. Sex Transm Dis 1997; 24:284-286.
32. Moller BR, Taylor-Robinson D, Furr PM. Serological evidence implicating Mycoplasma genitalium in pelvic inflammatory disease. Lancet 1984; 1:1102-1103.
33. Simms I, Eastick K, Mallinson H, et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease. J Clin Pathol 2003; 56:616-618. (Pubitemid 36976362)
34. Falk L, Fredlund H, Jensen JS. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma geni-talium or Chlamydia trachomatis infection. Sex Transm Infect 2005; 81:73-78.
35. Taylor-Robinson D. Mycoplasma genitalium - an up-date. Int J STD AIDS 2002; 13:145-151.
36. Anagrius C, Lore B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005; 81:458-462.
37. Keshavarz H, Duffy SW, Sadeghi-Hassanabadi A, et al. Risk factors for and relationship between bacterial vaginosis and cer-vicitis in a high risk population for cervicitis in Southern Iran. Eur J Epidemiol 2001; 17:89-95.
38. Peipert JF, Montagno AB, Cooper AS, et al. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol 1997; 177:1184-1187.
39. Willmott FE. Mucopurulent cervicitis: A clinical entity?. Geni-tourin Med 1988; 64:169-171.
40. Huppert JS, Mortensen JE, Reed JL, et al. Mycoplasma geni-talium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis 2008; 35:250-254.
41. Haggerty CL, Totten PA, Astete SG, et al. Mycoplasma geni-talium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006; 2006:30184.
42. Short VL, Totten PA, Ness RB, et al. Clinical presentation of Mycoplasma genitalium infection among women with pelvic inflammatory disease. Clin Infect Dis 2009; 48:41-47.
43. Schwebke JR, Weiss HL. Interrelationships of bacterial vaginosis and cervical inflammation. Sex Transm Dis 2002; 29:59-64.
44. Paavonen J, Roberts PL, Stevens CE, et al. Randomized treatment of mucopurulent cervicitis with doxycycline or amoxicillin. Am J Obstet Gynecol 1989; 161:128-135.
45. Falk L, Fredlund H, Jensen JS. Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex Transm Infect 2003; 79:318-319.
46. Bradshaw CS, Jensen JS, Tabrizi SN, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12:1149-1152